Skip to main content
. 2022 Sep 25;14(19):3981. doi: 10.3390/nu14193981

Table 2.

Patients’ characteristics.

Data Cohort
n = 55
Men
n = 37 (67.3%)
Women
n = 18 (32.7%)
Age, y 60 (52–67) 58 (52–67.5) 64 (50.5–67.8)
Comorbidities, n (%) Cardiovascular a 38 (69.1) 26 (70.3) 12 (66.7)
Respiratory b 15 (27.3) 12 (32.4) 3 (16.7)
Digestive c 26 (47.3) 19 (51.4) 7 (22.2)
Metabolic and endocrine d 20 (36.4) 13 (35.1) 7 (22.2)
Chronic kidney disease 28 (50.9) 22 (59.5) 6 (33.3)
Oncologic 6 (11) 3 ((8.1) 3 (16.7)
Chronic alcoholism 17 (30.9) 15 (40.5) 2 (11.1)
SAPS II 40 (25.7–54.5) 46 (24.7–64.3) 34 (24.5–45)
Admission reason, n (%) Medical 30 (54.5) 17 (45.9) 13 (72.2)
Surgical 25 (45.5) 20 (54.1) 5 (27.8)
Admission failure, n (%) Cardiovascular 21 (38.2) 16 (43.2) 5 (27.8)
Pulmonary 10 (18.2) 8 (21.6) 2 (11)
Neurologic 12 (21.8) 3 (8.2) 9 (50)
Digestive 5 (9) 4 (10.8) 1 (5.6)
Trauma 3 (5.5) 2 (5.4) 1 (5.6)
Other 4 (7.3) 4 (10.8) 0
Mechanical ventilation, n (%) 39 (70.9) 28 (75.7) 11 (61.1)
Duration of mechanical ventilation, days 6 (2–10) 5 (2–9) 7 (2–15)
Renal replacement therapy (RRT), n (%) 2 (3.6) 1 (2.7) 1 (5.6)
RRT duration, days 6 and 9 9 6
Insulin, n (%) 35 (63.6) 25 (67.6) 10 (55.6)
Insulin duration, days 6 (2–11) 6 (1.5–11.5) 6 (3.2–8.5)
Nutrition route, n (%) PO 17 (30.9) 13 (35.2) 4 (22.2)
PO + EN 6 (11) 4 (10.8) 2 (11)
EN 24 (43.6) 14 (37.8) 10 (55.6)
EN + PN 5 (9) 4 (10.8) 1 (5.6)
PN 3 (5.5) 2 (5.4) 1 (5.6)
ICU LOS, days 12 (7–16) 12 (7–16) 11.5 (7–17)
Hospital LOS, days 25 (17–41) 22 (17–32.2) 34 (20–58)

Data are expressed as median with lower and upper quartiles (Q1-Q3). EN: enteral nutrition; ICU: intensive care unit; LOS: length of stay; PO: per os; PN: parenteral nutrition; SAPS II: Simplified Acute Physiology Score. a Ischemic heart disease, valvular disease, cardiomyopathies, chronic heart disease, hypertension. b Asthma, chronic obstructive pulmonary disease and interstitial lung diseases. c Gastro-esophageal reflux, ulcers, digestive surgery, pancreatitis. d Hypo- or hyperthyroidism, hyperlipidemia.